Rejenevie™ Therapeutics Announces Start of Phase II Immune Restoration Treatment Clinical Trial
Rejenevie™ Therapeutics announced the commencement of the company’s Phase II clinical trial...
Read MoreRejenevie™ Therapeutics announced the commencement of the company’s Phase II clinical trial...
Read MoreIntroducing Portrait AI Face Journal, a groundbreaking new app revolutionizing the future of...
Read MoreA “second-generation” platelet concentrate called platelet-rich fibrin (PRF) might...
Read MoreDr Jay Calvert, President of the Rhinoplasty Society, says the preservation rhinoplasty technique...
Read MoreSkinCeuticals announces the arrival of two exciting, new retail kits delivering high quality,...
Read MoreBotulinum toxin injections like Botox® Cosmetic, Xeomin and Dysport, and the new Jeuveau remain...
Read MoreThe British Association of Aesthetic Plastic Surgeons (BAAPS); the only organisation solely...
Read More